CAPTRUST Financial Advisors
PROF

CAPTRUST Financial Advisors’s Profound Medical PROF Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,398
Closed -$67.4K – 3373
2026
Q1 		$67.4K Buy
+10,398
New +$71.8K ﹤0.01% 2865
2022
Q3 		– Sell
-6,000
Closed -$44K – 3527
2022
Q2 		$44K Hold
6,000
– – ﹤0.01% 2850
2022
Q1 		$54K Hold
6,000
– – ﹤0.01% 2731
2021
Q4 		$67K Hold
6,000
– – ﹤0.01% 2447
2021
Q3 		$88K Sell
6,000
-100
-2% -$1.52K ﹤0.01% 2177
2021
Q2 		$100K Hold
6,100
– – ﹤0.01% 2029
2021
Q1 		$123K Hold
6,100
– – ﹤0.01% 1805
2020
Q4 		$125K Buy
+6,100
New +$112K ﹤0.01% 1404

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

CAPTRUST Financial Advisors's PROF Position: Q2 2026 in Review

CAPTRUST Financial Advisors sold out of Profound Medical (PROF) in Q2 2026, closing a stake of 10,398 shares — an estimated $67.4K sold.

CAPTRUST Financial Advisors first reported a position in PROF in Q4 2020 and held it in 8 quarters. The position peaked at $125K in Q4 2020. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • CAPTRUST Financial Advisors reported no remaining Profound Medical position as of Q2 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,398 Profound Medical shares in Q2 2026, an estimated $67.4K.
  • CAPTRUST Financial Advisors first reported a position in Profound Medical in Q4 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Profound Medical position peaked at $125K in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.